AI analyzes CT scans to find safer radiation levels for liver cancer patients

NCT ID NCT07346573

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This completed study used artificial intelligence to examine CT scans from 274 liver cancer patients who had already received radiation therapy. The goal was to find the radiation dose that causes a visible liver reaction, which could help doctors avoid liver injury in future treatments. Researchers compared patients who developed this reaction with those who did not, looking at scan features and clinical information. Since this was a retrospective study, no new treatments or procedures were given to participants.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

What this could lead to
If successful, this could help doctors set safer radiation doses for liver cancer treatment, reducing the risk of liver injury.
What could go wrong
This is a retrospective observational study, so it can show patterns but cannot prove cause and effect. The findings may not apply to all patients or treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The Third Xiangya Hospital

    Changsha, Hunan, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.